Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint

Documents similaires

• Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target
  par: Samuel F. Acuff, et autres
  Publié: (2025)
• Commentary on ter Laak et al .: The importance of drug market information and differentiating drug use patterns
  par: Rory Verhagen, et autres
  Publié: (2024)
• N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis
  par: Emma L. Winterlind, et autres
  Publié: (2024)
• Commentary on Copeland et al.: Does xylazine in the United Kingdom foreshadow a European synthetic polysubstance drug crisis?
  par: Joseph R. Friedman
  Publié: (2024)
• Commentary on Qeadan et al .: Leveraging opportunities to expand the substance use disorder treatment arsenal
  par: Ty S. Schepis
  Publié: (2024)